Non-profit · founded 1946
Oklahoma Medical Research Foundation
Oklahoma City, United States · omrf.org
- Citations, last 5 years
- 16.2k
- Works, last 5 years
- 1 568
- h-index
- 435
- Scientists listed
- 236
- Grants since 2016
- 602
Grants received
2019–2022 · fellowship · F32
Skeletal Stem Cell PDGFR-beta Signaling as a New Regulator of the HSC Niche
Hae Ryong Kwon · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2025 · research · R35
Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
Andrew S Weyrich · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2025 · research · R01
Does insulin sensitivity impact the potential of metformin to slow aging?
Benjamin Francis Miller · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2025 · research · R01
Epigenome-Guided Causal Variant Discovery and Mechanisms
Patrick M Gaffney · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2026 · research · R35
Protease-Mediated Vascular Instability in Development and Disease
Courtney T Griffin · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2026 · research · R01
Does insulin sensitivity impact the potential of metformin to slow aging?
Benjamin Francis Miller · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2024 · research · R01
Sex divergence and cell specificity of age-related hippocampal DNA modifications
Willard M Freeman · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2024 · cooperative agreement · UM1
Oklahoma ACE: Molecular Deconstruction of Autoimmune Disease to Aid Clinical Trial Success
Judith A James · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2024 · research · R01
Epigenome-Guided Causal Variant Discovery and Mechanisms
Patrick M Gaffney · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2021 · research · R00
Molecular Mechanisms of Rapamycin - Induced Reversal of Cardiac Aging
Ying Ann Chiao · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2024 · research · R01
PDGF-regulated stem cells and bone disease
Lorin E Olson · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2026 · research · R35
Protease-Mediated Vascular Instability in Development and Disease
Courtney T Griffin · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2021 · research · R03
Epstein Barr Virus Interleukin 10 (vIL 10) in Systemic Lupus Erythematosus
Neelakshi Ramchandra Jog · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2029 · cooperative agreement · UM1
Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success
Judith A James · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2025 · research · R35
Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
Andrew S Weyrich · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2022 · research · R03
Epstein Barr Virus Interleukin 10 (vIL 10) in Systemic Lupus Erythematosus
Neelakshi Ramchandra Jog · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2022 · fellowship · Career Development Award
Metabolic regulation of lymphangiogenesis
Pengchun Yu · Oklahoma Medical Research Foundation · funded by American Heart Association
2019–2024 · cooperative agreement · UM1
Oklahoma ACE: Molecular Deconstruction of Autoimmune Disease to Aid Clinical Trial Success
Judith A James · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2026 · research · R35
Protease-Mediated Vascular Instability in Development and Disease
Courtney T Griffin · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2025 · research · R35
Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
Andrew S Weyrich · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2029 · cooperative agreement · UM1
Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success
Judith A James · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2019–2027 · research · R35
Protease-Mediated Vascular Instability in Development and Disease
Courtney T Griffin · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2023 · research · R01
Ikaros family genes and lupus susceptibility across ethnically diverse populations
Joel Marvin Guthridge · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2023 · research · R13
Summer Training Course in Experimental Aging Research
Holly Van Remmen · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2022 · research · R01
Epigenetic control of meiotic recombination in mammals - Equipment Supplement
Roberto Jose Pezza · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2019 · grant · S10
Biacore T200
Rodger Paul Mcever · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2022 · research · R01
Epigenetic control of meiotic recombination in mammals.
Roberto Jose Pezza · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2023 · research · R13
Summer Training Course in Experimental Aging Research
Holly Van Remmen · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2025 · research · R01
Specificity and Molecular Definition of Pathogenic Lymphocytes in Sjogren's Syndrome
A Darise Farris · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2023 · research · R01
Characterization of a distinct NKT subset and its role in influenza responses
Jose Alberola-Ila · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2022 · research · R01
Epigenetic control of meiotic recombination in mammals.
Roberto Jose Pezza · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2024 · research · R01
A 3D human tissue-engineered lung model to study immune responses to Respiratory Syncytial Virus
Heather Fahlenkamp · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2023 · program · P30
Oklahoma Rheumatic Disease Research Cores Center (Overall Application)
Judith A James · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2022 · research · R01
A 3D human tissue-engineered lung model to study immune responses to Respiratory Syncytial Virus
Heather Fahlenkamp · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2023 · research · R01
Characterization of a distinct NKT subset and its role in influenza responses
Jose Alberola-Ila · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2023 · research · R01
Specificity and Molecular Definition of Pathogenic Lymphocytes in Sjogren's Syndrome
A Darise Farris · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2022 · research · R01
A 3D human tissue-engineered lung model to study immune responses to Respiratory Syncytial Virus
Heather Fahlenkamp · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2022 · research · R01
Ikaros family genes and lupus susceptibility across ethnically diverse populations
Joel Marvin Guthridge · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2028 · program · P30
Oklahoma Rheumatic Disease Research Cores Center
Judith A James · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2018–2022 · research · R01
Mitochondrial Dynamics in RPE Homeostasis and Disease
Scott M Plafker · Oklahoma Medical Research Foundation · funded by National Institutes of Health